Insider Trading History of Pops Richard F

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Pops Richard F since 2015. This trader's CIK number is 1126490. At the time of last reporting, Pops Richard F was the Director of Neurocrine Biosciences Inc. (stock ticker symbol NBIX). Also see all insider trading activities at Neurocrine Biosciences Inc.

Note that in the past POPS RICHARD F also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Alkermes Plc. (ALKS) by Pops Richard F

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 ALKS 0 $0 347,257 $9,778,556 500,525 $7,447,499
2021 ALKS 0 $0 250,000 $5,464,850 309,275 $4,526,250
2020 ALKS 0 $0 325,000 $4,697,425 401,775 $3,815,500
2019 ALKS 0 $0 720,000 $16,785,178 774,375 $6,485,998
2018 ALKS 0 $0 170,000 $7,670,120 219,250 $2,089,299
2017 ALKS 0 $0 150,000 $8,224,775 204,250 $2,301,500
2016 ALKS 0 $0 213,750 $10,142,312 278,625 $3,674,662
2015 ALKS 0 $0 187,500 $13,300,112 230,500 $3,487,500

Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Pops Richard F

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 NBIX 0 $0 15,000 $2,364,765 15,000 $718,350
2025 NBIX 0 $0 0 $0 2,869 $0
2024 NBIX 0 $0 42,100 $5,792,619 44,199 $1,263,700
2023 NBIX 0 $0 30,000 $3,576,090 30,000 $381,300
2022 NBIX 0 $0 15,000 $1,144,470 15,000 $99,900
2018 NBIX 0 $0 13,747 $1,391,919 15,000 $105,750
2017 NBIX 0 $0 0 $0 15,000 $51,000
2016 NBIX 0 $0 15,000 $700,800 15,000 $46,050
2015 NBIX 0 $0 0 $0 15,000 $71,400

Yearly summary of insider trading at Acceleron Pharma Inc (XLRN) by Pops Richard F

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 XLRN 0 $0 37,500 $1,568,625 37,500 $190,500


Insider trading activities at 3 companies by Pops Richard F:

1. Alkermes Plc. (ALKS)

2. Neurocrine Biosciences Inc (NBIX)

3. Acceleron Pharma Inc (XLRN)

Table 1. Insider trading of Alkermes Plc. (ALKS) by Pops Richard F

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-05-06 ALKS Sale 93,747 27.86 2,611,322
2022-05-05 ALKS Sale 253,510 28.27 7,167,234
2022-05-06 ALKS Option Ex 120,847 16.55 2,000,017
2022-05-05 ALKS Option Ex 329,153 16.55 5,447,482
2022-02-21 ALKS Option Ex 32,400 .00 0
2022-02-16 ALKS Option Ex 18,125 .00 0
2021-05-18 ALKS Option Ex 150,000 18.11 2,715,750
2021-05-18 ALKS Sale 150,000 21.90 3,285,450
2021-05-06 ALKS Sale 100,000 21.79 2,179,400
2021-05-06 ALKS Option Ex 100,000 18.11 1,810,500
2021-02-21 ALKS Option Ex 32,400 .00 0
2021-02-16 ALKS Option Ex 18,125 .00 0
2021-02-17 ALKS Option Ex 8,750 .00 0
2020-05-14 ALKS Sale 75,000 15.00 1,125,225
2020-05-14 ALKS Option Ex 75,000 11.74 880,500
2020-05-07 ALKS Option Ex 50,000 11.74 587,000
2020-05-07 ALKS Sale 50,000 14.62 731,250
2020-04-02 ALKS Sale 50,000 13.79 689,500
2020-04-02 ALKS Option Ex 50,000 11.74 587,000
2020-03-26 ALKS Option Ex 75,000 11.74 880,500
2020-03-26 ALKS Sale 75,000 14.36 1,077,225
2020-03-19 ALKS Sale 75,000 14.32 1,074,225
2020-03-19 ALKS Option Ex 75,000 11.74 880,500
2020-03-01 ALKS Option Ex 17,500 .00 0
2020-02-21 ALKS Option Ex 32,400 .00 0
2020-02-16 ALKS Option Ex 18,125 .00 0
2020-02-17 ALKS Option Ex 8,750 .00 0
2019-11-14 ALKS Option Ex 100,000 9.21 921,000
2019-11-14 ALKS Sale 100,000 19.50 1,950,000
2019-11-07 ALKS Option Ex 69,795 9.21 642,811
2019-11-08 ALKS Option Ex 30,205 9.21 278,188
2019-11-07 ALKS Sale 69,795 19.81 1,382,638
2019-11-08 ALKS Sale 30,205 19.73 595,823
2019-09-19 ALKS Sale 100,000 21.54 2,153,600
2019-09-19 ALKS Option Ex 100,000 9.21 921,000
2019-09-12 ALKS Option Ex 100,000 9.21 921,000
2019-09-12 ALKS Sale 100,000 22.68 2,268,200
2019-09-05 ALKS Sale 100,000 20.18 2,017,800
2019-09-05 ALKS Option Ex 100,000 9.21 921,000
2019-05-16 ALKS Sale 60,000 25.42 1,525,260
2019-05-16 ALKS Option Ex 60,000 8.55 513,000
2019-05-23 ALKS Sale 50,000 24.22 1,211,150
2019-05-23 ALKS Option Ex 50,000 8.55 427,500
2019-03-12 ALKS Sale 44,171 33.24 1,468,464
2019-03-13 ALKS Sale 15,829 33.51 530,493
2019-03-12 ALKS Option Ex 44,171 8.55 377,662
2019-03-13 ALKS Option Ex 15,829 8.55 135,337
2019-03-05 ALKS Option Ex 50,000 8.55 427,500
2019-03-05 ALKS Sale 50,000 33.63 1,681,750
2019-03-01 ALKS Option Ex 17,500 .00 0
2019-02-26 ALKS Option Ex 10,000 .00 0
2019-02-17 ALKS Option Ex 8,750 .00 0
2019-02-16 ALKS Option Ex 18,125 .00 0
2018-05-22 ALKS Sale 20,000 45.68 913,620
2018-05-22 ALKS Option Ex 20,000 12.29 245,799
2018-05-15 ALKS Sale 50,000 46.38 2,319,100
2018-05-15 ALKS Option Ex 50,000 12.29 614,500
2018-05-08 ALKS Sale 50,000 44.41 2,220,550
2018-05-08 ALKS Option Ex 50,000 12.29 614,500
2018-05-01 ALKS Option Ex 50,000 12.29 614,500
2018-05-01 ALKS Sale 50,000 44.34 2,216,850
2018-03-01 ALKS Option Ex 17,500 .00 0
2018-03-03 ALKS Option Ex 13,000 .00 0
2018-02-26 ALKS Option Ex 10,000 .00 0
2018-02-17 ALKS Option Ex 8,750 .00 0
2017-11-02 ALKS Sale 50,000 48.87 2,443,400
2017-11-02 ALKS Option Ex 50,000 14.13 706,500
2017-05-28 ALKS Option Ex 13,750 .00 0
2017-05-24 ALKS Sale 25,000 57.42 1,435,525
2017-05-24 ALKS Option Ex 25,000 15.95 398,750
2017-05-17 ALKS Sale 50,000 58.22 2,911,050
2017-05-17 ALKS Option Ex 50,000 15.95 797,500
2017-05-10 ALKS Option Ex 25,000 15.95 398,750
2017-05-10 ALKS Sale 25,000 57.39 1,434,800
2017-03-03 ALKS Option Ex 13,000 .00 0
2017-03-01 ALKS Option Ex 17,500 .00 0
2017-02-26 ALKS Option Ex 10,000 .00 0
2016-11-29 ALKS Sale 30,000 57.32 1,719,690
2016-11-29 ALKS Option Ex 30,000 14.38 431,400
2016-11-22 ALKS Option Ex 30,000 14.38 431,400
2016-11-22 ALKS Sale 30,000 58.94 1,768,050
2016-11-15 ALKS Sale 30,000 59.03 1,771,050
2016-11-15 ALKS Option Ex 30,000 14.38 431,400
2016-11-08 ALKS Option Ex 30,000 14.38 431,400
2016-11-08 ALKS Sale 30,000 53.44 1,603,080
2016-10-05 ALKS Option Ex 20,000 .00 0
2016-05-28 ALKS Option Ex 13,750 .00 0
2016-05-21 ALKS Option Ex 8,125 .00 0
2016-04-19 ALKS Sale 18,750 40.15 752,868
2016-04-19 ALKS Option Ex 18,750 20.79 389,812
2016-04-12 ALKS Sale 25,000 38.00 950,024
2016-04-12 ALKS Option Ex 25,000 20.79 519,750
2016-03-22 ALKS Option Ex 25,000 20.79 519,750
2016-03-22 ALKS Sale 25,000 31.71 792,650
2016-03-15 ALKS Option Ex 25,000 20.79 519,750
2016-03-15 ALKS Sale 25,000 31.40 784,900
2016-03-03 ALKS Option Ex 13,000 .00 0
2016-02-26 ALKS Option Ex 10,000 .00 0
2015-12-07 ALKS Option Ex 37,500 18.60 697,500
2015-12-07 ALKS Sale 37,500 72.63 2,723,662
2015-12-01 ALKS Option Ex 50,000 18.60 930,000
2015-12-01 ALKS Sale 50,000 72.64 3,632,000
2015-09-17 ALKS Sale 50,000 71.23 3,561,450
2015-09-17 ALKS Option Ex 50,000 18.60 930,000
2015-09-10 ALKS Option Ex 50,000 18.60 930,000
2015-09-10 ALKS Sale 50,000 67.66 3,383,000
2015-05-28 ALKS Option Ex 13,750 .00 0
2015-05-20 ALKS Option Ex 8,125 .00 0
2015-05-21 ALKS Option Ex 8,125 .00 0
2015-03-03 ALKS Option Ex 13,000 .00 0

Table 2. Insider trading of Neurocrine Biosciences Inc (NBIX) by Pops Richard F

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-05-15 NBIX Option Ex 15,000 47.89 718,350
2026-05-15 NBIX Sale 15,000 157.65 2,364,765
2025-05-22 NBIX Option Ex 2,869 .00 0
2024-05-17 NBIX Option Ex 4,199 .00 0
2024-05-17 NBIX Sale 2,100 141.84 297,859
2024-03-13 NBIX Option Ex 23,200 42.76 992,032
2024-03-13 NBIX Sale 23,200 140.33 3,255,632
2024-03-11 NBIX Option Ex 100 42.76 4,276
2024-03-08 NBIX Option Ex 1,700 42.76 72,692
2024-03-11 NBIX Sale 100 140.00 14,000
2024-03-08 NBIX Sale 1,700 140.05 238,078
2024-02-20 NBIX Option Ex 15,000 12.98 194,700
2024-02-20 NBIX Sale 15,000 132.47 1,987,050
2023-01-03 NBIX Sale 15,000 119.20 1,788,045
2023-01-03 NBIX Option Ex 15,000 12.71 190,650
2023-01-03 NBIX Option Ex 15,000 12.71 190,650
2023-01-03 NBIX Sale 15,000 119.20 1,788,045
2022-05-09 NBIX Sale 15,000 76.30 1,144,470
2022-05-09 NBIX Option Ex 15,000 6.66 99,900
2018-11-26 NBIX Sale 4,124 91.36 376,789
2018-11-12 NBIX Sale 4,123 103.30 425,893
2018-10-29 NBIX Sale 5,500 107.13 589,237
2018-05-01 NBIX Option Ex 15,000 7.05 105,750
2017-05-03 NBIX Option Ex 15,000 3.40 51,000
2016-05-25 NBIX Sale 15,000 46.72 700,800
2016-05-16 NBIX Option Ex 15,000 3.07 46,050
2015-05-11 NBIX Option Ex 15,000 4.76 71,400

Table 3. Insider trading of Acceleron Pharma Inc (XLRN) by Pops Richard F

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-03-06 XLRN Sale 37,500 41.83 1,568,625
2018-03-06 XLRN Option Ex 37,500 5.08 190,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pops Richard F (Director of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.